CTNM — CONTINEUM THERAPEUTICS INC
As of Q2 2026, 29 SEC-registered investment managers reported holding CTNM (CONTINEUM THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $181.75M across 11.12M shares. That is -8.1% by share count (-985.81K shares) versus the previous quarter, while reported value moved +15.1%. Ownership is concentrated: the five largest holders account for 66.7% of reported value and the top ten for 89.6%.
Compared with the prior quarter, 6 opened new positions, 10 added to existing stakes, 10 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CTNM is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Janus Henderson Group history | Q1 2026 | 2.73M | $35.59M | 0.02% | Add |
| BlackRock Inc history | Q2 2026 | 2.06M | $33.83M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 1.84M | $30.14M | 0.01% | Hold |
| Balyasny Asset Management history | Q2 2026 | 1.52M | $24.96M | 0.03% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 1.04M | $17.05M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 931.71K | $15.27M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 1.27M | $14.53M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 693.19K | $11.36M | 0.00% | Add |
| Hillhouse Capital (HHLR Advisors) history | Q2 2026 | 669.34K | $10.97M | 1.32% | Hold |
| Goldman Sachs Group history | Q2 2026 | 497.25K | $8.15M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 396.35K | $6.50M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 277.80K | $4.55M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 214.08K | $3.51M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 150.80K | $2.47M | 0.00% | Add |
| Casdin Capital history | Q2 2026 | 148.33K | $2.43M | 0.12% | Hold |
| UBS Group AG history | Q2 2026 | 130.64K | $2.14M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 118.06K | $1.93M | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 67.30K | $1.10M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 65.60K | $1.08M | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 51.62K | $846.02K | 0.00% | Reduce |
New Positions (Q2 2026)
- BNY Mellon 65.60K sh · $1.08M
- Deutsche Bank AG 26.22K sh · $429.68K
- Wells Fargo & Co 22.51K sh · $368.94K
- Invesco Ltd 15.77K sh · $258.49K
- JPMorgan Chase & Co 13.48K sh · $202.22K
- Legal & General Investment Management America 2.61K sh · $42.84K
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 2.73M sh · $35.59M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | 404.77K | 603.58K | 616.62K | 165.45K | 322.03K | 536.15K | 669.12K | 2.06M |
| Franklin Resources | 627.01K | 1.45M | 1.45M | 1.58M | 1.70M | 1.66M | 1.88M | 1.84M | 1.84M |
| Balyasny Asset Management | — | — | — | — | — | 951.32K | 1.84M | 1.69M | 1.52M |
| Fidelity Management & Research (FMR) | 323.60K | 696.93K | 691.88K | 810.32K | 843.15K | 814.87K | 814.87K | 814.87K | 1.04M |
| Millennium Management | — | — | — | — | 132.38K | 665.22K | 830.69K | 1.54M | 931.71K |
| Geode Capital Management | 156.42K | 128.68K | 188.41K | 193.05K | 71.30K | 211.05K | 213.87K | 282.04K | 693.19K |
| Hillhouse Capital (HHLR Advisors) | 669.34K | 669.34K | 669.34K | 669.34K | 669.34K | 669.34K | 669.34K | 669.34K | 669.34K |
| Goldman Sachs Group | — | — | 26.36K | 14.22K | 60.92K | 30.14K | 105.59K | 307.11K | 497.25K |
| Citadel Advisors | 127.78K | — | — | — | 16.49K | — | — | 350.20K | 396.35K |
| Northern Trust Corp | 19.38K | 62.72K | 89.26K | 83.63K | 25.17K | 48.96K | 53.88K | 65.93K | 277.80K |
| Charles Schwab Investment Management | 51.77K | 43.30K | 55.33K | 51.20K | 26.04K | 110.18K | 110.06K | 144.01K | 214.08K |
| Wellington Management Group | — | — | — | — | — | — | — | 55.61K | 150.80K |
| Casdin Capital | 296.67K | 296.67K | 296.67K | 148.33K | 148.33K | 148.33K | 148.33K | 148.33K | 148.33K |
| UBS Group AG | 2.11K | 2.66K | 24.88K | 13.29K | 7.67K | 68.50K | 199.39K | 230.41K | 130.64K |
| Marshall Wace | — | — | 10.84K | 31.08K | 28.68K | 193.49K | 180.80K | 226.30K | 118.06K |
| Renaissance Technologies | — | — | — | — | 14.40K | 41.20K | 57.10K | 69.40K | 67.30K |
| BNY Mellon | 20.23K | 14.16K | 18.74K | 19.90K | — | — | — | — | 65.60K |
| Morgan Stanley | 11.86K | 20.40K | 26.56K | 57.16K | 92.90K | 93.00K | 124.29K | 70.80K | 51.62K |
| Bank of America Corp | 4.47K | 5.59K | 9.13K | 5.77K | 1.21K | 7.24K | 9.27K | 47.45K | 46.57K |
| Two Sigma Investments | — | — | — | — | 60.96K | 37.94K | 37.92K | 37.92K | 30.35K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details